Can oseltamivir be co‑administered with amoxicillin‑clavulanate (amoxiclav) tablets?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, oseltamivir can be safely co-administered with amoxicillin-clavulanate (amoxiclav)

There are no clinically significant drug interactions between oseltamivir and amoxicillin-clavulanate, and no dose adjustments are required when these medications are used together 1.

Evidence for Co-Administration Safety

The FDA drug label for oseltamivir explicitly states that no clinically relevant pharmacokinetic interactions have been observed when coadministering oseltamivir with amoxicillin 1. This is further reinforced in the prescribing information, which confirms that no dose adjustments are needed for either oseltamivir or amoxicillin when these drugs are given concomitantly 1.

Clinical Context for Combined Use

This combination is commonly used in clinical practice when:

  • Influenza with suspected bacterial superinfection: Patients with influenza who develop secondary bacterial complications (such as bacterial pneumonia, sinusitis, or otitis media) may require both antiviral and antibiotic therapy
  • Empirical treatment in severe cases: Hospitalized patients with influenza-like illness where bacterial co-infection cannot be excluded

Recent research supports the use of oseltamivir-antibiotic combinations in severe influenza cases. A 2020 study demonstrated that oseltamivir-antibiotic combination therapy showed earlier resolution of symptoms (particularly fever, cough, and nasal congestion) and reduced mean symptom severity scores in hospitalized patients with severe influenza A and B infections compared to oseltamivir alone 2.

Pharmacologic Rationale

The lack of interaction is explained by the distinct metabolic pathways:

  • Oseltamivir is converted to its active form (oseltamivir carboxylate) primarily by esterases in the liver, not through cytochrome P450 enzymes or glucuronyl transferases 1
  • Amoxicillin-clavulanate does not compete for these esterases or interfere with oseltamivir's renal excretion
  • Both drugs have low protein binding, minimizing displacement interactions 1

Important Caveats

While the combination is safe, be aware that:

  • Gastrointestinal side effects may be additive: Both medications can cause nausea, vomiting, and diarrhea. Oseltamivir's GI effects are reduced when taken with food 3, and this same strategy applies when using both drugs together
  • Ensure appropriate indication for antibiotics: Do not reflexively add antibiotics to oseltamivir without clinical evidence of bacterial infection, as this contributes to antimicrobial resistance
  • Timing matters for oseltamivir: Antiviral efficacy is greatest when initiated within 48 hours of symptom onset 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.